Clinical Trial Report

Current Oncology Reports

, Volume 12, Issue 6, pp 352-354

The Addition of Rituximab to Fludarabine and Cyclophosphamide Improves Progression-free Survival in Patients with Previously Treated Chronic Lymphocytic Leukemia

  • Amit MahipalAffiliated withDivision of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Kimmel Cancer Center, Thomas Jefferson University
  • , Mark WeissAffiliated withDivision of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology, Kimmel Cancer Center, Thomas Jefferson University Email author 

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access